Cardiovascular Risk Clinical Trials

4 recruiting

Frequently Asked Questions

Common questions about Cardiovascular Risk clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Not Applicable

Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study

ObesityHypertensionOverweight+4 more
Universidad Católica San Antonio de Murcia220 enrolled1 locationNCT07447362
Recruiting
Phase 3

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled229 locationsNCT07181109
Recruiting
Not Applicable

Sleep and Circadian Mechanisms in Hypertension

Cardiovascular DiseasesHypertensionSleep+2 more
Oregon Health and Science University32 enrolled1 locationNCT05184933
Recruiting
Not Applicable

Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)

Heart FailureCardiovascular Risk Factors
Idoven 1903 S.L.1,968 enrolled5 locationsNCT07113223
Recruiting
Not Applicable

Akershus Cardiac Examination (ACE) 5 Study

Lung Cancer ScreeningHeavy SmokersCardiovascular Risk Profile+1 more
University Hospital, Akershus1,000 enrolled1 locationNCT07301489
Recruiting

Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure

Heart Failure With Reduced Ejection FractionCardiovascular Risk FactorHeart Failure With Mid Range Ejection Fraction+2 more
Massachusetts General Hospital3,000 enrolled1 locationNCT03480633
Recruiting
Phase 2

Reducing Systemic Inflammation in People on Antiretroviral Therapy

Cardiovascular Risk FactorHuman Immunodeficiency Virus (HIV)
Centre hospitalier de l'Université de Montréal (CHUM)150 enrolled1 locationNCT07030920
Recruiting

Diurnal BP Patterns in Those at Increased Risk of CVD

Arterial StiffnessChronic Kidney DiseasesBlood Pressure+1 more
University of Edinburgh120 enrolled1 locationNCT04522765
Recruiting

Prevalence and Risk Factors asSOciated With CArdiac comorbiDIty in psoriAsis

Heart FailureCardiovascular DiseasesStroke+21 more
Herlev and Gentofte Hospital1,000 enrolled1 locationNCT04950218
Recruiting

Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk

HypertensionCardiovascular RiskBlood Pressure Check (Hypertension Screening)
Aktiia SA15,000 enrolled2 locationsNCT06670677
Recruiting

The Effect of Multidisciplinary Care Approach on CV Risk Modification in CaP Patients Receiving ADT

Prostate CancerCardiovascular Risk
Chinese University of Hong Kong130 enrolled1 locationNCT06163924
Recruiting

Types of Intracellular Bacteria in Atherosclerotic Plaques and Analysis of Risk Factors

DiabetesCarotid Artery StenosisHyperlipidemia+6 more
Tang-Du Hospital200 enrolled1 locationNCT06935279
Recruiting
Phase 4

Intervention for High-normal Blood Pressure in Adults With Type 2 Diabetes

Blood PressureDiabetes Mellitus, Type 2Adverse Event+2 more
XueQing Yu11,414 enrolled1 locationNCT03264352
Recruiting
Not Applicable

Impact of Mediterranean Diet in Cardiovascular Risk Among People With HIV

HIV InfectionCardiovascular RiskInflammation+1 more
Parc de Salut Mar64 enrolled1 locationNCT06757309
Recruiting
Phase 2

Lumasiran in Hyperoxalaemic Patients on Haemodialysis

Cardiovascular DiseaseCardiovascular Risk FactorChronic Kidney Disease Requiring Chronic Dialysis+2 more
Charite University, Berlin, Germany50 enrolled1 locationNCT06225544
Recruiting
Not Applicable

The Influence of Mitochondrial-Derived Reactive Oxygen Species on Racial Disparities in Neurovascular Function

Blood PressureCardiovascular Risk FactorRenal Function+1 more
Auburn University60 enrolled1 locationNCT04334135
Recruiting
Not Applicable

LIVES: Personalized Lifestyle Intervention for Patients With Depression

Cardiovascular RiskDepression BipolarDepression, Unipolar
University Medical Center Groningen38 enrolled2 locationsNCT05767073
Recruiting
Not Applicable

Metabolic Syndrome in Diabetic Smokers Using Cigarettes & Combustion-Free Nicotine Delivery Systems

Diabetes Mellitus, Type 2Cardiovascular Risk Factor
Eclat Srl.576 enrolled1 locationNCT04231838